RESPECT

Relating Expectations and needs to Participation and Empowerment of children in Clinical Trials

 Coordinatore GOETEBORGS UNIVERSITET 

 Organization address address: VASAPARKEN
city: GOETEBORG
postcode: 405 30

contact info
Titolo: Dr.
Nome: Margareta
Cognome: Ahlqwist
Email: send email
Telefono: +46 31 786 5345
Fax: +46 31 786 4355

 Nazionalità Coordinatore Sweden [SE]
 Sito del progetto http://www.patientneeds.eu
 Totale costo 560˙144 €
 EC contributo 500˙000 €
 Programma FP7-HEALTH
Specific Programme "Cooperation": Health
 Code Call FP7-HEALTH-2007-A
 Funding Scheme CSA-SA
 Anno di inizio 2008
 Periodo (anno-mese-giorno) 2008-06-01   -   2011-08-31

 Partecipanti

# participant  country  role  EC contrib. [€] 
1    GOETEBORGS UNIVERSITET

 Organization address address: VASAPARKEN
city: GOETEBORG
postcode: 405 30

contact info
Titolo: Dr.
Nome: Margareta
Cognome: Ahlqwist
Email: send email
Telefono: +46 31 786 5345
Fax: +46 31 786 4355

SE (GOETEBORG) coordinator 0.00
2    AZIENDA OSPEDALIERA DI PADOVA

 Organization address address: Via Giustiniani 1
city: PADOVA
postcode: 35128

contact info
Titolo: Dr.
Nome: Antonio
Cognome: Giona
Email: send email
Telefono: +39 049 821 3585
Fax: +39 049 875 3865

IT (PADOVA) participant 0.00
3    CONSORZIO PER VALUTAZIONI BIOLOGICHE E FARMACOLOGICHE

 Organization address address: VIA LUIGI PORTA 14
city: PAVIA
postcode: 27100

contact info
Titolo: Prof.
Nome: Adriana
Cognome: Ceci
Email: send email
Telefono: +39 382 25075
Fax: +39 382 536544

IT (PAVIA) participant 0.00
4    FORUM EUROPEEN DES PATIENTS (FPE)

 Organization address address: RUE DICKS 14
city: LUXEMBOURG
postcode: 1417

contact info
Titolo: Ms.
Nome: Nicola
Cognome: Bedlington
Email: send email
Telefono: +32 2 401 61 73
Fax: +32 2 401 68 68

LU (LUXEMBOURG) participant 0.00
5    GOOD CLINICAL PRACTICE ALLIANCE - EUROPE

 Organization address address: RUE WASHINGTON STRAAT 40
city: BRUSSEL
postcode: 1050

contact info
Titolo: Mr.
Nome: Francis P.
Cognome: Crawley
Email: send email
Telefono: 3216350369
Fax: 3216350369

BE (BRUSSEL) participant 0.00
6    UNIVERSITAETSKLINIKUM HAMBURG-EPPENDORF

 Organization address address: Martinistrasse 52
city: HAMBURG
postcode: 20246

contact info
Titolo: Prof.
Nome: Monika
Cognome: Bullinger
Email: send email
Telefono: +49 404 28036430
Fax: +49 40 428034749

DE (HAMBURG) participant 0.00
7    UNIVERZITETNI KLINICNI CENTER LJUBLJANA

 Organization address address: ZALOSKA CESTA 002
city: LJUBLJANA
postcode: 1000

contact info
Titolo: Ms.
Nome: Darinka
Cognome: Miklavcic
Email: send email
Telefono: +38 6 1 522 2290
Fax: +38 61 522 2482

SI (LJUBLJANA) participant 0.00

Mappa


 Word cloud

Esplora la "nuvola delle parole (Word Cloud) per avere un'idea di massima del progetto.

workshop    encourage    clinical    expectations    harmonization    children    regulation    drugs    realised    patients    respect    examined    child    health    patient    stage    participate    construct    broad    presented    participation    empowerment    families    motivating    recruitment    empowering    paediatric    basis    trials    medical    motivations   

 Obiettivo del progetto (Objective)

'There are two objectives for this project, firstly to clarify the expectations and needs of children and their families who have participated or who might participate in clinical trials for new drugs in Europe. Secondly, to identify methods by which the expectations and needs can be translated into empowering and motivating participants in future clinical trails research. This will be achieved in three stages. The partners will be from different areas involving patients, clinicians, regulators, and researchers (industrial and academic) on a broad basis in order to cover a broad spectrum of diseases. Stage 1) The project will construct a basis for coordination and harmonization. This will involve a literature search and a preliminary workshop. We will build a web site for communication within the project and with a wider audience. Stage 2) We will ground our diverse experience and knowledge through benchmarking good practice case studies, and collecting opinions from patients’ organisations in Europe. The results will be presented at an expert harmonization workshop composed of all partners of the project. This workshop will identify the operating procedures needed to encourage empowerment and increase motivation for participation in clinical trials. Stage 3) The results of the project will be presented in a series of European conferences. This will ensure that the impact on clinical practice will be facilitated. This will help to improve translational research which depends upon the clinical trial process being undertaken with large enough populations to ensure safety of new products. Greater participation in clinical trials research will result in more valid and reliable products available for children as envisaged by the EC 1901/2006 Paediatric Regulation. In addition it will make European health businesses more competitive and will improve the global health in Europe.'

Introduzione (Teaser)

A group of EU-funded researchers responded to the EU's Seventh Framework Programme call for a coordination study identifying patients' needs in the context of clinical trials.

Descrizione progetto (Article)

The http://www.patientneeds.eu/ ('Relating expectations and needs to participation and empowerment of children in clinical trials') (RESPECT) project examined opportunities for improving recruitment to clinical trials by empowering children and their parents. Prompted by the 2007 European paediatric regulation, team members investigated the reasons for participation and explored a model of empowerment.

In order to gain extended health-care benefits and cost savings, the RESPECT consortium identified the needs of children and their families as these relate to clinical trials of new drugs in Europe. They also examined methods for translating these needs into empowering and motivating participants in future clinical trials' research.

These aims were realised though work covering three objectives. The first was to construct a common basis for understanding, and the second was to collect and analyse various approaches and practices for recruiting patients into clinical trials in different medical areas and conditions. The third was to disseminate project findings to open up the debate and encourage the adoption of better empowerment and recruitment methodologies.

Project partners utilised a range of methodologies to analyse current European patient perspectives on clinical trials, selecting and adapting them according to the specific groups studied and the project's needs. Case study interviews and surveys were used for child participants and potential participants in clinical trials. The main emphasis was on obtaining qualitatively rich data that included the families' stories of why they agreed to participate and why they continued to participate.

RESPECT research has improved our understanding of patient needs, attitudes, expectations, motivations and perceived barriers to participation in clinical trials. Among the findings of the coordinated action was that parent- and child-friendly clinical trials will likely increase participation and transparency. Patient organisations are key to effecting change in this respect. Another finding was that immigrants are frequently excluded from clinical trials, based on the assumption that they will not understand the instructions because of low educational levels. This points to a need to be more inclusive and provide cultural mediation, not just translation.

RESPECT project efforts and activities have produced high-quality research, identifying the needs and motivations of children and their families taking part in clinical trials. Enhanced networking and a stronger and more fruitful coordination of different actors having an equal role has been realised. This will benefit both research and patients. Project results can be applied to all medications and all medical conditions, and are also transferable to adult clinical trials.

Altri progetti dello stesso programma (FP7-HEALTH)

PRIMA-EDS (2012)

Polypharmacy in chronic diseases: Reduction of Inappropriate Medication and Adverse drug events in elderly populations by electronic Decision Support

Read More  

TELOMARKER (2008)

"Identification and characterization of novel human telomere-related biomarkers that aid cancer management by improving patient diagnosis, treatment selection, response monitoring, and drug development"

Read More  

ENAROMATIC (2008)

European Network for Advanced Research on Olfaction for Malaria Transmitting Insect Control

Read More